Skip to main content
. 2020 Apr 24;2020:8159342. doi: 10.1155/2020/8159342

Table 4.

The risk of inflammatory cells to miRNA ratios for MetS.

Models OR (95% CI) P value
LT18R
 Univariate model 2.5 (1.6–3.7) <0.001
 Binary model 1 3.8 (1.9, 7.7) <0.001∗∗
 Binary model 2 2.8 (1.0, 7.5) 0.049∗∗∗
LT22R
 Univariate model 1.3 (1.1–1.6) 0.003
 Binary model 1 1.2 (1.0, 1.5) 0.03∗∗
 Binary model 2 1.5 (1.0, 2.2) 0.093∗∗∗
MT18R
 Univariate model 61.6 (9.1–417.2) <0.001
 Binary model 1 279.3 (14.1, 5533.6) <0.001∗∗
 Binary model 2 510.6 (1.0, 279892.1) 0.053∗∗∗
MT22R
 Univariate model 3.4 (1.5–7.9) 0.005
 Binary model 1 2.9 (1.2, 7.2) 0.022∗∗
 Binary model 2 6.2 (0.5, 73.6) 0.151∗∗∗
PT18R
 Univariate model 2.1 (1.4–3.0) <0.001
 Binary model 1 3.1 (1.7, 5.6) <0.001∗∗
 Binary model 2 2.5 (1.0, 6.0) 0.047∗∗∗
PT22R
 Univariate model 1.3 (1.1–1.5) 0.003
 Binary model 1 1.2 (1.0, 1.4) 0.03∗∗
 Binary model 2 1.4 (0.9, 2.0) 0.094∗∗∗

Legend: this table shows the logistic regression analysis for the risk of inflammatory cells to miRNA ratios for MetS. P value calculated without any adjustment. ∗∗P value adjusted for age, gender, and physical activity. ∗∗∗Further adjustment for WC based on model 1. Abbreviations: LT18R: lymphocyte to miR-18a-5p ratio; LT22R: lymphocyte to miR-22-3p ratio; MT18R: monocyte to miR-18a-5p ratio; MT22R: monocyte to miR-22-3p ratio; PT18R: PBMCs to miR-18a-5p ratio; PT22R: PBMCs to miR-22-3p ratio; OR: odds ratio; CI: confidence interval.